BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15196263)

  • 1. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease.
    Stanford M; Whittall T; Bergmeier LA; Lindblad M; Lundin S; Shinnick T; Mizushima Y; Holmgren J; Lehner T
    Clin Exp Immunol; 2004 Jul; 137(1):201-8. PubMed ID: 15196263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit.
    Sun JB; Czerkinsky C; Holmgren J
    Scand J Immunol; 2010 Jan; 71(1):1-11. PubMed ID: 20017804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit.
    Phipps PA; Stanford MR; Sun JB; Xiao BG; Holmgren J; Shinnick T; Hasan A; Mizushima Y; Lehner T
    Eur J Immunol; 2003 Jan; 33(1):224-32. PubMed ID: 12594851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and function of inducible costimulator on peripheral blood CD4+ T cells in Behçet's patients with uveitis: a new activity marker?
    Usui Y; Takeuchi M; Yamakawa N; Takeuchi A; Kezuka T; Ma J; Matsuda R; Okunuki Y; Akiba H; Goto H
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5099-104. PubMed ID: 20445113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's disease.
    Koarada S; Haruta Y; Tada Y; Ushiyama O; Morito F; Ohta A; Nagasawa K
    Rheumatology (Oxford); 2004 Jul; 43(7):843-51. PubMed ID: 15150429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
    Tognon S; Graziani G; Marcolongo R
    Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
    Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal expression of chemokine receptors in Behçet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations.
    Houman H; Hamzaoui A; Ben Ghorbal I; Khanfir M; Feki M; Hamzaoui K
    J Autoimmun; 2004 Nov; 23(3):267-73. PubMed ID: 15501397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease.
    Imamura Y; Kurokawa MS; Yoshikawa H; Nara K; Takada E; Masuda C; Tsukikawa S; Ozaki S; Matsuda T; Suzuki N
    Clin Exp Immunol; 2005 Feb; 139(2):371-8. PubMed ID: 15654837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells.
    George Chandy A; Hultkrantz S; Raghavan S; Czerkinsky C; Lebens M; Telemo E; Holmgren J
    Immunology; 2006 Jul; 118(3):311-20. PubMed ID: 16827892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease.
    Akman A; Sallakci N; Coskun M; Bacanli A; Yavuzer U; Alpsoy E; Yegin O
    Br J Dermatol; 2006 Aug; 155(2):350-6. PubMed ID: 16882174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of a recombinant cholera toxin B subunit-insulin B chain peptide hybrid protein by Brevibacillus choshinensis expression system as a nasal vaccine against autoimmune diabetes.
    Yuki Y; Hara-Yakoyama C; Guadiz AA; Udaka S; Kiyono H; Chatterjee S
    Biotechnol Bioeng; 2005 Dec; 92(7):803-9. PubMed ID: 16142801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possibility of inducing anterior chamber-associated immune deviation by TGF-beta2 treatment of monocytes isolated from Behcet's patients.
    Takeuchi M; Keino H; Suzuki J; Usui Y; Hattori T; Takeuchi A; Oh-I K; Okunuki Y; Kezuka T; Usui M
    Exp Eye Res; 2006 Oct; 83(4):981-8. PubMed ID: 16822510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic surveillance of autoimmunity in Behcet's disease with uveitis: selenium binding protein is a novel autoantigen in Behcet's disease.
    Okunuki Y; Usui Y; Takeuchi M; Kezuka T; Hattori T; Masuko K; Nakamura H; Yudoh K; Usui M; Nishioka K; Kato T
    Exp Eye Res; 2007 May; 84(5):823-31. PubMed ID: 17343851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis.
    Chi W; Zhu X; Yang P; Liu X; Lin X; Zhou H; Huang X; Kijlstra A
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3058-64. PubMed ID: 18579762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis.
    El-Asrar AM; Struyf S; Kangave D; Al-Obeidan SS; Opdenakker G; Geboes K; Van Damme J
    Clin Immunol; 2011 May; 139(2):177-84. PubMed ID: 21334264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis.
    Ohno S; Nakamura S; Hori S; Shimakawa M; Kawashima H; Mochizuki M; Sugita S; Ueno S; Yoshizaki K; Inaba G
    J Rheumatol; 2004 Jul; 31(7):1362-8. PubMed ID: 15229958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.
    Holmgren J; Adamsson J; Anjuère F; Clemens J; Czerkinsky C; Eriksson K; Flach CF; George-Chandy A; Harandi AM; Lebens M; Lehner T; Lindblad M; Nygren E; Raghavan S; Sanchez J; Stanford M; Sun JB; Svennerholm AM; Tengvall S
    Immunol Lett; 2005 Mar; 97(2):181-8. PubMed ID: 15752556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors.
    Aeberli D; Seitz M; Jüni P; Villiger PM
    Rheumatology (Oxford); 2005 Feb; 44(2):172-5. PubMed ID: 15509629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation.
    D'Ambrosio A; Colucci M; Pugliese O; Quintieri F; Boirivant M
    J Leukoc Biol; 2008 Sep; 84(3):661-8. PubMed ID: 18562485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.